Kimberly-Clark Corporation (KMB) SEC Filings & Earnings Calls
EquiReason read 20 Kimberly-Clark Corporation SEC filings in the last 12 months. Latest: 8-K on 2026-10-20 — Filing references a press release but provides no substantive event details; appears to be a procedural 8-K with only exhibit listing..
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
- Market cap
- 36.6B
- P/E TTM
- 18.7
- Dividend yield
- 4.6%
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
20 Oct 20268-K · 8.01Filing references a press release but provides no substantive event details; appears to be a procedural 8-K with only exhibit listing.open
Risks flagged
No risk signals can be extracted due to lack of substantive content in the filing excerpt.
15 Oct 20268-K · 2.02, 7.01Kimberly-Clark reaffirms 2026 outlook: organic sales growth ~100bps below category growth, adj. operating profit mid-single-digit growth, adj. EPS high-single-digit growth, adj. EPS attributable low-single-digit decline. Preliminary Q3 resuopen
Guidance
FY2026 organic sales growth ~100bps below category growth; adjusted operating profit mid-single-digit growth; adjusted EPS from continuing ops high-single-digit growth; adjusted EPS attributable low-single-digit decline
Reaffirmed 2026 outlook with specific growth targets; organic sales growth lags category due to China disruptions, but margin improvement expected.
Risks flagged
China social media disruptions impacting organic sales growth by ~100bps
“unfavorable impacts amounting to approximately 100 basis points at a total company level from previously disclosed China social media disruptions” · word for word
13 Oct 20268-K · 8.01Kimberly-Clark announces exchange offers for up to $7.0B of Kenvue notes for new KMB notes and cash, related to pending acquisition of Kenvue.open
Risks flagged
Increased leverage from acquisition and debt issuance may pressure credit metrics.
“Exchange Offers for up to $7.0B of new notes; acquisition expected to close in Q4 2026.”
1 Oct 20268-K · 5.02Russell Torres, President and COO, notified departure effective November 2, 2026 to pursue other opportunities.open
Risks flagged
Loss of a key executive (President and COO) may disrupt operations and strategy, especially if no successor is named.
“Russell Torres, the Corporation’s President and Chief Operating Officer, notified the Corporation that he will depart the Corporation effective November 2, 2026 to pursue other opportunities.” · word for word
28 Sep 20268-KKimberly-Clark files financial statements for Kenvue acquisition; includes audited Kenvue financials and pro forma combined statements for the Mergers.acquisitionopen
Risks flagged
Integration risk and potential dilution from acquisition
“Pro forma financial information for the Mergers”
4 Aug 202610-QKimberly-Clark reported Q2 2026 results with revenue growth and margin expansion, but net income declined due to discontinued operations and acquisition costs.earningsopen
Figures in the filing · each found in the filing text
| Net Sales · Q2-2026 | $4.19B | +1% y/y |
| Gross Profit · Q2-2026 | $1.60B | +10% y/y |
| Operating Profit · Q2-2026 | $633M | +7% y/y |
| Net Income Attributable to Kimberly-Clark Corporation · Q2-2026 | $345M | -32% y/y |
| Diluted Earnings per Share from Continuing Operations · Q2-2026 | $1.22 | -8% y/y |
| Cash Provided by Operations · H1-2026 | $1.65B | +51% y/y |
| Capital Spending · H1-2026 | $776M | +94% y/y |
| NA Segment Operating Profit · North America · Q2-2026 | $725M | +11% y/y |
| IPC Segment Operating Profit · International Personal Care · Q2-2026 | $186M | +2% y/y |
Risks flagged
Kenvue Acquisition Integration Risk
“Completion of the Kenvue Acquisition, which is expected to take place in the second half of 2026, remains subject to the satisfaction of other customary closing conditions.” · word for word
Discontinued Operations Loss
“Income (Loss) from Discontinued Operations, Net of Income Taxes $ (60) $ 68” · word for word
Transformation Initiative Execution Risk
“Total pre-tax costs are anticipated to be approximately $1.5 billion, with cash costs expected to be approximately 60% of that amount.” · word for word
4 Aug 20268-K · 2.02Kimberly-Clark reported Q2 2026 net sales of $4.2B (+0.6%), adjusted gross margin up 190bps to 38.8%, adjusted EPS from continuing ops $1.80 (+10.4%). Raised FY2026 outlook. China social media disruption impacted diaper sales.earningsopen
Figures in the filing · each found in the filing text
| Net sales · Q2-2026 | $4.20B | +1% y/y |
| Gross margin · Q2-2026 | 38.3% | |
| Adjusted gross margin · Q2-2026 | 38.8% | |
| Operating profit · Q2-2026 | $633M | +7% y/y |
| Adjusted operating profit · Q2-2026 | $757M | +6% y/y |
| Diluted EPS from continuing operations · Q2-2026 | $1.22 | -8% y/y |
| Adjusted EPS from continuing operations · Q2-2026 | $1.80 | +10% y/y |
| Net interest expense · Q2-2026 | $49M | -21% y/y |
| Effective tax rate · Q2-2026 | 37.9% | |
| Adjusted effective tax rate · Q2-2026 | 21.1% |
Guidance
FY2026 revenue raised to $5.63-5.71B from $5.40-5.48B; Q4 EPS $12.10-12.58; FY2026 capex ~$1.5B; gross margin 35.5-36.0%
Raised FY2026 guidance on strong first-half performance, despite China disruption
Risks flagged
China social media disruption impacting diaper sales and near-term profits
“The impact from the spread of false claims across social media significantly impacted the Company’s diaper sales in China in the second quarter and is expected to further impact sales and profits in the near term.” · word for word
Pending Kenvue acquisition integration and financing risks
“Our pending acquisition of Kenvue remains on track to close by the end of this year. ... risks and uncertainties around the pending mergers with Kenvue (including the risk that the anticipated benefits and synergies of the mergers may not be realized when expected or at all, the terms and scope of the expected financing in connection with the mergers may pro”
5 May 20268-K · 5.02Reported a director or officer change (departure, election, appointment or pay arrangement)open
Risks flagged
Potential temporary gap in accounting oversight; mitigated by CFO assuming role.
“Andrew Scribner ... will depart ... CFO ... will act as principal accounting officer on an interim basis.”
28 Apr 20268-K · 2.02Net Sales $4.20B (+3% y/y); Organic Sales Growth 2.5; Adjusted Gross Margin 37.9earningsopen
Figures in the filing · each found in the filing text
| Net Sales · Q1-2026 | $4.20B | +3% y/y |
| Organic Sales Growth · Q1-2026 | 2.5% | |
| Adjusted Gross Margin · Q1-2026 | 37.9% | |
| Adjusted Operating Profit · Q1-2026 | $732M | +4% y/y |
| Adjusted EPS from Continuing Operations · Q1-2026 | $1.60 | -1% y/y |
| Adjusted EPS attributable to Kimberly-Clark · Q1-2026 | $1.97 | +2% y/y |
Guidance
Reaffirms 2026 outlook, CEO cites momentum and Kenvue acquisition opportunity.
Risks flagged
Gross margin pressure from pricing investments and supply chain costs.
“adjusted gross margin was 37.9 percent, a decrease of 60 basis points versus the prior year as strong productivity savings were more than offset by unfavorable pricing net of cost inflation” · word for word
Higher adjusted effective tax rate impacting EPS.
“adjusted effective rate was 26.2 percent compared to 20.7 percent in the prior year, primarily reflecting discrete unfavorable factors”
28 Apr 202610-QRisks named: Input cost inflation from oil pricesopen
Risks flagged
Input cost inflation from oil prices
“assuming oil prices remain at $100 per barrel for the remainder of the year, we estimate incremental input costs of approximately $200 (prior to consideration of mitigation actions) during the remainder of 2026” · word for word
23 Mar 2026DEF 14AKimberly-Clark filed its 2026 proxy statement, detailing executive compensation, governance, and shareholder proposals, including the pending Kenvue acquisition.open
Figures in the filing · each found in the filing text
| Net Sales · FY2025 | $16.40B | -2% y/y |
| Organic Sales Growth · FY2025 | 1.7% | |
| Gross Margin · FY2025 | 36.0% | |
| Adjusted Gross Margin · FY2025 | 37.3% | |
| Operating Profit · FY2025 | $2.40B | -11% y/y |
| Adjusted Operating Profit · FY2025 | $2.70B | 0% y/y |
| Diluted Earnings Per Share · FY2025 | $6.07 | -20% y/y |
| Adjusted Earnings Per Share · FY2025 | $7.53 | +3% y/y |
| North America Segment Revenue · North America · FY2025 | $10.80B | |
| International Personal Care Segment Revenue · International Personal Care · FY2025 | $5.70B |
Risks flagged
Macroeconomic and Cost Headwinds
“management did not achieve its financial targets for 2025, mostly due to a more challenging macro environment, pricing pressures, and higher input cost inflation including tariffs.” · word for word
Integration Risk from Kenvue Acquisition
“The announcement of our pending acquisition of Kenvue to create a $32 billion global health and wellness leader.” · word for word
Joint Venture Execution Risk
“The announcement of a strategic joint venture with Suzano and our International Family Care & Professional (IFP) business.” · word for word
12 Feb 202610-KNet Sales $16.45B (-2% y/y); Net Income Attributable to Kimberly-Clark Corporation $2.02B (-21% y/y); Diluted Earnings Per Share - Continuing Operations $4.86 (-24% y/y)open
Figures in the filing · each found in the filing text
| Net Sales · FY2025 | $16.45B | -2% y/y |
| Net Income Attributable to Kimberly-Clark Corporation · FY2025 | $2.02B | -21% y/y |
| Diluted Earnings Per Share - Continuing Operations · FY2025 | $4.86 | -24% y/y |
| NA Segment Net Sales · NA · FY2025 | $10.75B | -2% y/y |
| IPC Segment Net Sales · IPC · FY2025 | $5.69B | -1% y/y |
| NA Segment Operating Profit · NA · FY2025 | $2.55B | +0% y/y |
| IPC Segment Operating Profit · IPC · FY2025 | $796M | -4% y/y |
| Capital Spending · FY2025 | $1.02B | +69% y/y |
Risks flagged
Integration risk from Kenvue acquisition
“On November 2, 2025, we entered into an Agreement and Plan of Merger to acquire the outstanding equity interests of Kenvue, Inc.” · word for word
Tax law change impact
“During the year ended December 31, 2025, we recorded incremental tax charges of approximately $145 primarily relating to a valuation allowance on current and prior year U.S. foreign tax credits.” · word for word
Legal and regulatory exposure
“We have been party to certain legal proceedings relating to our former health care business, Avanos Medical, Inc.” · word for word
29 Jan 20268-K · 5.07, 7.01Submitted matters to a vote of security holders; issued a Regulation FD disclosure (forward guidance or material update)open
Risks flagged
Regulatory approvals still required; integration risk remains.
“subject to the receipt of regulatory approvals and satisfaction of other customary closing conditions” · word for word
27 Jan 20268-K · 2.02Net sales $4.10B (-1% y/y); Organic sales growth 2.1; Adjusted gross margin 37earningsopen
Figures in the filing · each found in the filing text
| Net sales · Q4-2025 | $4.10B | -1% y/y |
| Organic sales growth · Q4-2025 | 2.1% | |
| Adjusted gross margin · Q4-2025 | 37.0% | |
| Adjusted operating profit · Q4-2025 | $629M | +13% y/y |
| Adjusted EPS · Q4-2025 | $1.86 | +24% y/y |
| Full year net sales · FY2025 | $16.40B | -2% y/y |
| Full year organic sales growth · FY2025 | 1.7% |
Risks flagged
Net sales declined 0.6% in Q4 and 2.1% for full year due to private label diaper exit and FX headwinds.
“Net sales of $4.1 billion, down 0.6 percent, with organic sales growth of 2.1 percent was offset by a 2.5 percent decline primarily from the exit of the company's private label diaper business in the US.” · word for word
Tariff-related costs impacted full-year gross margin by 100 bps.
“incremental tariff-related costs” · word for word
16 Jan 20268-K · 8.01Disclosed a material event under other events (litigation, recall, contract loss, or major announcement)open
Risks flagged
Litigation risk from multiple shareholder lawsuits seeking to enjoin merger; potential for delay or additional disclosure costs.
“Four complaints filed in different jurisdictions alleging material omissions in proxy statement; demand letters also received.”
4 Dec 20258-K · 8.01Disclosed a material event under other events (litigation, recall, contract loss, or major announcement); filed financial statements and exhibits with this reportopen
Risks flagged
No new risk signals; recast is purely administrative.
“Filing states no revisions for other information, developments, or events since original filing.”
7 Nov 20258-K · 5.02Reported a director or officer change (departure, election, appointment or pay arrangement)open
Risks flagged
Loss of key technology leadership could impact digital transformation initiatives.
“Departure of Chief Digital and Technology Officer.”
3 Nov 20258-K · 1.01, 7.01, 8.01Entered a material definitive agreement (acquisition, partnership, or major contract); issued a Regulation FD disclosure (forward guidance or material update)open
Risks flagged
Integration risk; regulatory approvals required; shareholder votes needed.
“This communication does not constitute an offer to sell or the solicitation of an offer to buy ... No offering of securities shall be made except by means of a prospectus” · word for word
30 Oct 202510-QKimberly-Clark reported Q3 2025 net income down 51% YoY due to margin compression and a $130M tax charge from OBBBA.earningsopen
Figures in the filing · each found in the filing text
| Net Sales · Q3-2025 | $4.15B | +0% y/y |
| Gross Profit · Q3-2025 | $1.49B | -5% y/y |
| Net Income Attributable to Kimberly-Clark Corporation · Q3-2025 | $446M | -51% y/y |
| Operating Cash Flow · 9M-2025 | $1.80B | -25% y/y |
| Effective Tax Rate · Q3-2025 | 45.4% |
Risks flagged
Tax Policy Risk
“During the three months ended September 30, 2025, we recorded incremental tax charges of approximately $130 primarily relating to a valuation allowance on current and prior year U.S. foreign tax credits.” · word for word
Margin Compression
“Gross Profit $1,493M vs $1,564M; Operating Profit $621M vs $1,026M.”
30 Oct 20258-K · 2.02Net sales $4.20B (+0% y/y); Organic sales growth 2.5; Adjusted gross margin 36.8; Guidance: Updates 2025 Outlookearningsopen
Figures in the filing · each found in the filing text
| Net sales · Q3-2025 | $4.20B | 0% y/y |
| Organic sales growth · Q3-2025 | 2.5% | |
| Adjusted gross margin · Q3-2025 | 36.8% | |
| Adjusted EPS attributable to Kimberly-Clark · Q3-2025 | $1.82 | 0% y/y |
| Diluted EPS attributable to Kimberly-Clark · Q3-2025 | $1.34 | -50% y/y |
| Adjusted operating profit · Q3-2025 | $683M | 0% y/y |
| Gross margin · Q3-2025 | 36.0% |
Guidance
Updates 2025 Outlook
Full year outlook updated to reflect solid performance in dynamic environment, but margin pressure from tariffs and price investments persists.
Risks flagged
Tariff-driven costs are pressuring gross margins, with adjusted gross margin down 170 bps YoY
“incremental tariff-driven costs” · word for word
Planned price investments to improve price:value tiers are negatively impacting margins
“planned investments to improve price:value tiers across the portfolio” · word for word
Effective tax rate increased significantly to 45.4% (reported) and 26.5% (adjusted) due to OBBBA and prior year tax resolutions
“The third quarter effective tax rate was 45.4 percent, compared to 19.4 percent in the prior year. On an adjusted basis, the effective rate was 26.5 percent compared to 21.5 percent in the prior year.” · word for word
Kimberly-Clark Corporation — questions
- What did Kimberly-Clark Corporation file recently?
- 20 SEC filings in the last 12 months. Latest: 8-K on 2026-10-20 — Filing references a press release but provides no substantive event details; appears to be a procedural 8-K with only exhibit listing.
Every figure on this page comes from Kimberly-Clark Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.